Recall Record

San Jose, CA, United States

Becton, Dickinson and Company, BD Biosciences recalls

11 recalls recorded since 2018, most recently on 8 May 2024. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls11
Ongoing (FDA)4
Terminated or completed7
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
8 May 2024
Reason
Multitest with compromised raw material used to assess immune system status may result in flow cytometry plot with unusual staining pattern, nonspecific aggregates, high background, double positive event increase on CD3+CD4+vsCD3+CD8+ and/or CD3-CD16+CD56+vsCD3-CD19+, contaminated antibodies, may lead to erroneous or delayed results, additional patient sample, might impact healthcare decisions
Distribution
US: MN, NJ, NY, MD, UT, FL, NC, MA, KY, NE, NV, CA, LA, DC, OH, MI, PA, WA, CT, AL, DE, TN, IN, OR, IL, WI, NH, TX, GA, RI, SD, ID, NM, AR. OUS: CA, SG, NZ, AU, KR, IN, PE, GT, AR, MX, TW, CN, NI, CR, JP, BR, TH, BE, VN
Initiated
Voluntary: Firm initiated
Recall number
Z-2351-2024

Ongoing Class II Medical devices

Recall started
25 October 2023
Reason
In vitro diagnostics product that impacts the quality of cell staining can cause low or dim fluorescence signal, which can lead to potential false negative results and misdiagnosis of hematological malignancy, delayed treatment, and the need for additional patient samples.
Distribution
Worldwide - US Nationwide distribution including in the states of IL, MN, FL, MI, MD, NC, NY, CA, GA, AR, KS, PA, NH, TX, OK, MA, MO, DC, AZ, IN, NJ, TN, WA, VA, CT and the countries of CA, BE, SG, HK, TW, BR, MY, IN, BO, PE, JP, MX, CL, KR, UY, AU.
Initiated
Voluntary: Firm initiated
Recall number
Z-0641-2024

Ongoing Class II Medical devices

Recall started
3 October 2022
Reason
Due to partial label detachment on tubes. This can cause tubes to become stuck together in the pouch or cause automation errors when used with the automated loader for the wash assistant.
Distribution
U.S.: AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, VA, VT, WA, and WI O.U.S.: Argentina, Australia, Belgium, Bolivia, Brazil, Canada, Chile, China, Columbia, Costa Rica, Dominican Republi
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0173-2023, Z-0172-2023, Z-0171-2023

Ongoing Class II Medical devices

Recall started
25 March 2022
Reason
Anti-Kappa APC & Anti-Kappa PE analyte reagents may exhibit uncharacteristic flow profiles.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AL, CA, CO, DC, DE, FL, IA, IL, IN, LA, MA, MD, ME, MI, MN, MO, NC, ND, NY, OH, OK, PA, TN, TX, UT, VA, WA, WI, WV and the country of Taiwan.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1215-2022, Z-1214-2022

Terminated Class II Medical devices

Recall started
22 July 2021
Terminated
24 March 2023
Reason
Complaints have been received for performance issues related to high background and staining. this issues is related to a manufacturing process error that can potentially cause a false positive staining due to contamination with another antibody.
Distribution
Worldwide distribution - U.S. Nationwide distribution in the states of CT, FL, KY, NY, and PA. The country of Taiwan.
Initiated
Voluntary: Firm initiated
Recall number
Z-2333-2021

Terminated Class II Medical devices

Recall started
5 October 2020
Terminated
11 March 2022
Reason
Recent product complaints showing an unexpected cell population exhibiting dim CD3 expression that may result in inaccurate results gating.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, CA, CO, CT, DE, FL, GA, IL, IN, KY, MA, MD, MI, NC, NJ, NV, NY, OH, OK, PA, PR, RI, SD, TN, TX, and VA. The countries of Canada, Belgium, Korea, India, Ecuador, Japan, Costa Rica, Australia, Vietnam, Pakistan, Singapo
Initiated
Voluntary: Firm initiated
Recall number
Z-0562-2021

Terminated Class II Medical devices

Recall started
31 March 2020
Terminated
27 April 2021
Reason
False positive reaction on the reagent.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, CT, FL, GA, IL, IN, LA, MA, MD, MI, MN, MO, NC, NH, NJ, NM, NV, NY, OH, OK, PA, TN, TX, VA, WA, WI and Puerto Rico. The countries of Argentina, Australia, Belgium, Brazil, Canada, China, Hong Kong, India,
Initiated
Voluntary: Firm initiated
Recall number
Z-1971-2020

Terminated Class II Medical devices

Recall started
19 August 2019
Terminated
12 April 2024
Reason
Flow cytometers, when used with specific tubes may experience excessive electronic abort counts (electronic abort count of beads exceeds 1.0% of the total processed events), which may affect the ratio of cell population events to bead events, potentially resulting in falsely high absolute counts. This may affect the following: initiation of prophylactic therapy for Opportunistic Infections (HIV patients), decisions regarding care/management (PID/immune suppressed patients), laboratory developed tests/experiments, specimen engraftment potency, and use of leucoreduced blood products for transfusion.
Distribution
U.S.: CA, KS, NJ, MI, NY, PA, IL, IN, VA, WA, MD, IA, OK, RI, FL, CO, OH, TX, TN, GA, MO, MN, HI, VT, MA, NE. O.U.S. (Foreign): Germany, Italy, South Korea, Japan, United Kingdom, Poland, France, Belgium, Canada, Latvia, India, Taiwan, Ireland, Algeria, Israel, Iraq, Netherlands, Malaysia, Austra
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0074-2020, Z-0066-2020, Z-0068-2020, Z-0070-2020, Z-0069-2020, Z-0067-2020, Z-0073-2020, Z-0071-2020, Z-0072-2020

Terminated Class II Medical devices

Recall started
8 July 2019
Terminated
31 January 2023
Reason
The recalling firm confirmed that BD FACS Sample Prep Assistant (SPA) II and III users may encounter probes with unacceptable wear prior to reaching the 2500 piercings guideline indicated in the Instructions for Use (IFU). When the probe is worn, particles from the rubber cap are more likely to clog the probe, resulting in blocked or inadequate sample dispense.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, CO,CT, GA, IL, MA, MI, MD, NC, NH,NJ, NY, OH, PA, TN, TX, VA, and VT. The countries of Australia, Botswana, Brazil, Canada, Chile, China, Colombia, Costa Rica, Europe, Hong Kong, India, Italy, Jamaica, Japan, Ka
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2356-2020, Z-2358-2020, Z-2357-2020

Terminated Class III Medical devices

Recall started
2 January 2019
Terminated
7 May 2021
Reason
A customer site was identified to have three FACSLyric IVD systems with FACSuite clinical v1.1.1 installed on a computer workstation with windows 10 operating system (OS). Windows 10 OS is not a released configuration for clinical use. It is released for research use only.
Distribution
US Distribution in MD.
Initiated
Voluntary: Firm initiated
Recall number
Z-0792-2019

Terminated Class III Medical devices

Recall started
16 May 2018
Terminated
13 August 2018
Reason
The solenoid plunger tip length is too short resulting in insufficient engagement to the Universal Loader enclosure to lock during use.
Distribution
US Distribution was made to FL, KS, KY, MA, NJ, and SD.
Initiated
Voluntary: Firm initiated
Recall number
Z-2598-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.